Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.

Journal Article (Journal Article;Multicenter Study)

BACKGROUND: Use of surgery for the treatment of infective endocarditis (IE) as related to surgical indications and operative risk for mortality has not been well defined. METHODS AND RESULTS: The International Collaboration on Endocarditis-PLUS (ICE-PLUS) is a prospective cohort of consecutively enrolled patients with definite IE from 29 centers in 16 countries. We included patients from ICE-PLUS with definite left-sided, non-cardiac device-related IE who were enrolled between September 1, 2008, and December 31, 2012. A total of 1296 patients with left-sided IE were included. Surgical treatment was performed in 57% of the overall cohort and in 76% of patients with a surgical indication. Reasons for nonsurgical treatment included poor prognosis (33.7%), hemodynamic instability (19.8%), death before surgery (23.3%), stroke (22.7%), and sepsis (21%). Among patients with a surgical indication, surgical treatment was independently associated with the presence of severe aortic regurgitation, abscess, embolization before surgical treatment, and transfer from an outside hospital. Variables associated with nonsurgical treatment were a history of moderate/severe liver disease, stroke before surgical decision, and Staphyloccus aureus etiology. The integration of surgical indication, Society of Thoracic Surgeons IE score, and use of surgery was associated with 6-month survival in IE. CONCLUSIONS: Surgical decision making in IE is largely consistent with established guidelines, although nearly one quarter of patients with surgical indications do not undergo surgery. Operative risk assessment by Society of Thoracic Surgeons IE score provides prognostic information for survival beyond the operative period. S aureus IE was significantly associated with nonsurgical management.

Full Text

Duke Authors

Cited Authors

  • Chu, VH; Park, LP; Athan, E; Delahaye, F; Freiberger, T; Lamas, C; Miro, JM; Mudrick, DW; Strahilevitz, J; Tribouilloy, C; Durante-Mangoni, E; Pericas, JM; Fernández-Hidalgo, N; Nacinovich, F; Rizk, H; Krajinovic, V; Giannitsioti, E; Hurley, JP; Hannan, MM; Wang, A; International Collaboration on Endocarditis (ICE) Investigators*,

Published Date

  • January 13, 2015

Published In

Volume / Issue

  • 131 / 2

Start / End Page

  • 131 - 140

PubMed ID

  • 25480814

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.114.012461


  • eng

Conference Location

  • United States